Leading Research Institute at Northeastern Opens Advanced Regulatory Analysis Center

The Barnett Institute of Chemical and Biological Analysis at Northeastern University has received a generous leadership gift from Louis Barnett and his family which will help launch the new Center
for Advanced Regulatory Analysis (CARA), including the GMP/GLP (Good Manufacturing Practices/Good Laboratory Practices) Regulatory
Laboratory. The $3 million donation includes a $1 million challenge grant from the family whose 1983 endowment gift is responsible for
the name of the internationally recognised research Institute. Devised in collaboration with leaders of the biotechnology industry, CARA
will play a critical role in ensuring drug safety and quality for all consumers by being a centre that focuses on the regulatory analysis of
biotechnology products, including biosimilars, and will serve as a resource to those pharmaceutical companies developing new drugs. The GMP/GLP Regulatory Laboratory will validate methods developed in the research arm, as well as conduct regulatory analysis.

“We are grateful to the Barnett family for their on-going support of the pioneering endeavours of the institute. They are helping us launch a new initiative that has enormous implications for human health and well-being,” said Joseph E. Aoun, President of Northeastern University. “We are trying to advance the science of regulatory analysis and we wouldn`t be where we are without the Barnetts` generous financial
support,” said Professor Barry Karger, Director of the Barnett Institute of Chemical and Biological Analysis at Northeastern. “One of the most important things we can do is come up with creative ways of interacting with industry, government, and health-care institutions.”
The efforts of the new centre are expected to have a global impact on the biotechnology industry. CARA will develop first-rate druganalysis
methods by working to produce new instruments for use in regulatory environments and by training scientists in the latest techniques.